Supplier profile
TEVA GmbH
Every public-sector award we hold for this supplier, across Germany, from 8 Nov 2010 to 6 Oct 2025.
Awards won
86
all time
Attributed value
€14
64 shared, unvalued
Buyers
24
public bodies
Active
2010–2025
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| IKK classic | 18 | not attributable |
| Techniker Krankenkasse | 13 | €1 |
| DAK-Gesundheit | 11 | not attributable |
| AOK Nordost – Die Gesundheitskasse | 8 | not attributable |
| AOK Baden-Württemberg | 5 | not attributable |
| GWQ ServicePlus AG | 4 | €10 |
| Barmer GEK | 3 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 2 | not attributable |
| AOK Nordwest – Die Gesundheitskasse | 2 | €1 |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Stabsbereich Recht; Referat Zentrale Vergabestelle | 2 | not attributable |
What they win
Awards
Showing 1–25 of 86 awards we hold
- Amantadin FTA - TK, hkk, HEK (ATC-Code: N04BB01) ↗Techniker Krankenkasseshared awardawarded 6 Oct 2025
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 25 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 20 Sept 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Jun 2025
- Azelastin und Fluticason 17-propionat - TK, hkk, HEK (ATC-Code: R01AD28) ↗Techniker Krankenkasseshared awardawarded 23 Dec 2024
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 21 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Amoxicillin fest (EU) - TK, hkk, HEK (ATC-Code: J01CA04) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026 ↗DAK-Gesundheitshared awardawarded 2 Aug 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026 ↗DAK-Gesundheitshared awardawarded 1 Aug 2024
- Germany – Pharmaceutical products – post_Arzneimittelausschreibung_2024 b ↗IKK classicshared awardawarded 27 Jul 2024
- Germany – Pharmaceutical products – post_Arzneimittelausschreibung_2024 a ↗IKK classicshared awardawarded 27 Jul 2024
- 001 | Acetylsalicylsäure Tabletten magensaftresistent u.w. [3] [H] ↗IKK classicshared awardawarded 26 Jul 2024
- 131 | Mesalazin Tabletten magensaftresistent [1] ↗IKK classicshared awardawarded 26 Jul 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 12 Jun 2024
- Germany – Pharmaceutical products – Abschluss von nicht nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 30 Jan 2024
- Germany-Bochum: Pharmaceutical products ↗Deutsche Rentenversicherung Knappschaft-Bahn-Seeshared awardawarded 27 Oct 2023
- Germany-Düsseldorf: Pharmaceutical products ↗GWQ ServicePlus AG€10awarded 18 Sept 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dabigatran, ATC B01AE07 für die Zeit 01.09.2023 - 31.08.2025 ↗DAK-Gesundheitshared awardawarded 2 Sept 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dabigatran, ATC B01AE07 für die Zeit 01.09.2023 - 31.08.2025 ↗DAK-Gesundheitshared awardawarded 1 Sept 2023
- Germany-Dresden: Pharmaceutical products ↗IKK classicshared awardawarded 9 Aug 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glatirameracetat (ausschließlich Darreichungsform PEN), ATC L03AX13 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitawarded 2 Jul 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fremanezumab, ATC N02CD03 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitawarded 2 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glatirameracetat (ausschließlich Darreichungsform PEN), ATC L03AX13 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitawarded 1 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fremanezumab, ATC N02CD03 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitawarded 1 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lipegfilgrastim, ATC L03AA14 für die Zeit 01.02.2023 - 31.01.2025 ↗DAK-Gesundheitshared awardawarded 1 Feb 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glatirameracetat, ATC L03AX13 für die Zeit 01.12.2022 - 30.11.2024 ↗DAK-Gesundheitshared awardawarded 1 Dec 2022
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- TEVA39 awards
- TEVA GmbH (BG TEVA ratiopharm GbR)8 awards
- TEVA NV8 awards
- TEVA GmbH [BG TEVA / ORION Pharma GbR (ratiopharm, TEVA, ORION Pharma)]2 awards
- TEVA GmbH (BG TEVA ratiopharm)2 awards
- TEVA SAS2 awards
- TEVA, S.L.2 awards
- Teva AB1 award
- TEVA GmbH (BG TEVA/Hexal GbR)1 award
- TEVA GmbH (BG TEVA / ORION Pharma GbR)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.